PDCI Market Access, a Division of McKesson Canada Corporation has released a whitepaper investigating the design and sustainability ... Read More
News
16
Sep2024
28
Jun2024
PMPRB Releases Long Awaited Discussion Guide as Phase 2 of the New Guidelines Consultation Process
/ PMPRB, What's New
On Wednesday, June 26th, PMPRB initiated Phase 2 of the consultation process by publishing the Discussion Guide that ... Read More
31
Jan2024
CADTH Update Introduces Streamlined Economic Reports and Launches BIA Template Consultation
/ CADTH, What's New
On Friday, CADTH’s Pharmaceutical Reviews Update – Issue 43 introduced a number of updates pertaining to its Reimbursement ... Read More
14
Nov2023
First Step of The New Guidelines Consultation Announced
On October 25, 2023, the Patented Medicine ... Read More
13
Nov2023
On November 10, 2023, the Patented Medicine Prices Review Board (PMPRB) launched first phase of its consultation process ... Read More
02
Oct2023
On September 27, 2023, the Patented Medicine Prices Review Board (PMPRB) published its final decision regarding the Amended ... Read More
08
Sep2023
Mississauga, ON - September 11, 2023 – Canada’s leading biopharmaceutical pricing and reimbursement consultancy, PDCI Market Access (PDCI), ... Read More
05
Sep2023
On September 5, 2023, the pan-Canadian Pharmaceutical Alliance (pCPA) announced the appointment of Douglas Clark as its first ... Read More